Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 076582
Company: HIKMA
Company: HIKMA
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
FENOLDOPAM MESYLATE | FENOLDOPAM MESYLATE | EQ 10MG BASE/ML | INJECTABLE;INJECTION | Prescription | AP | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
10/12/2004 | ORIG-1 | Approval |
Review (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/076582Orig1s000.pdf |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
03/30/2011 | SUPPL-7 | Labeling-Package Insert |
Label is not available on this site. |
FENOLDOPAM MESYLATE
INJECTABLE;INJECTION; EQ 10MG BASE/ML
TE Code = AP
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
CORLOPAM | FENOLDOPAM MESYLATE | EQ 10MG BASE/ML | INJECTABLE;INJECTION | Prescription | Yes | AP | 019922 | HOSPIRA |
FENOLDOPAM MESYLATE | FENOLDOPAM MESYLATE | EQ 10MG BASE/ML | INJECTABLE;INJECTION | Prescription | No | AP | 076582 | HIKMA |
FENOLDOPAM MESYLATE | FENOLDOPAM MESYLATE | EQ 10MG BASE/ML | INJECTABLE;INJECTION | Prescription | No | AP | 077155 | SANDOZ |